Nicole R. Hadas, SVP, Chief Legal Officer at Akebia Therapeutics, Inc. (AKBA), sold 7,411 shares at $1.52 ($11K) on 2024-02-27, disclosed to the SEC on 2024-02-29.
Scheduled sale ($11k) by SVP, Chief Legal Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| AKBA | SELL | 2023-05-25 | $154K | — | Filing → |
| AKBA | SELL | 2023-03-03 | $11K | — | Filing → |
| AKBA | SELL | 2023-03-01 | $5K | — | Filing → |